Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
6.45K
-
Shares change
-
-123M
-
Total reported value, excl. options
-
$52.9K
-
Value change
-
-$84.3M
-
Number of buys
-
2
-
Number of sells
-
-154
-
Price
-
$25.84
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q2 2025
164 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.45K shares
of 20.8M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include IFP Advisors, Inc (4.52K shares), Parallel Advisors, LLC (1.05K shares), EverSource Wealth Advisors, LLC (810 shares), Rise Advisors, LLC (49 shares), AllSquare Wealth Management LLC (18 shares), HUNTINGTON NATIONAL BANK (1 shares), LRI Investments, LLC (1 shares), Kaufman Rossin Wealth, LLC (0 shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (0 shares), and US Asset Management LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.